clinical trial · NCT05827016
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Bristol-Myers Squibb·phase3·active not recruiting·n = 1,230
Multiple MyelomaIberdomideLenalidomide
brief summary
The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).
started
Jun 22, 2023
primary completion
Mar 15, 2029
completion
Jan 1, 2036
last updated
Jul 2, 2026
official title
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol